Sortilin levels are associated with peripheral arterial disease in type 2 diabetic subjects

Influence of micro- and macro-vascular disease and Tumor Necrosis Factor Receptor 1 on the level of lower-extremity amputation in patients with type 2 diabetes

(2018) Fabrice Schneider et al.   Cardiovascular Diabetology

Autophagy Is Required for Sortilin-Mediated Degradation of Apolipoprotein B100Novelty and Significance

(2018) Jaume Amengual et al.   CIRCULATION RESEARCH

Transcriptional control of intestinal cholesterol absorption, adipose energy expenditure and lipid handling by Sortilin

(2018) Sumihiko Hagita et al.   Scientific Reports

Lower extremity arterial disease in patients with diabetes: a contemporary narrative review

(2018) Mathilde Nativel et al.   Cardiovascular Diabetology

Increased sortilin and its independent effect on circulating proprotein convertase subtilisin/kexin type 9 (PCSK9) in statin-naive patients with coronary artery disease

(2017) Die Hu et al.   INTERNATIONAL JOURNAL OF CARDIOLOGY

Rivaroxaban with or without Aspirin in Stable Cardiovascular Disease

(2017) John W. Eikelboom et al.   NEW ENGLAND JOURNAL OF MEDICINE

Sortilin and Its Multiple Roles in Cardiovascular and Metabolic Diseases

(2017) Claudia Goettsch et al.   ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY

Soluble sortilin is released by activated platelets and its circulating levels are associated with cardiovascular risk factors

(2016) Kazuyuki Ogawa et al.   ATHEROSCLEROSIS

Effects of Statin Therapy on Plasma Proprotein Convertase Subtilisin/kexin Type 9 and Sortilin Levels in Statin-Naive Patients with Coronary Artery Disease

(2016) Tsuyoshi Nozue et al.   Journal of Atherosclerosis and Thrombosis

TLR signals posttranscriptionally regulate the cytokine trafficking mediator sortilin

(2016) Toshiki Yabe-Wada et al.   Scientific Reports

Macrophage Sortilin Promotes LDL Uptake, Foam Cell Formation, and Atherosclerosis

(2015) K. M. Patel et al.   CIRCULATION RESEARCH

Introduction: Table 1

(2015)   DIABETES CARE

Insulin Resistance Induces Posttranslational Hepatic Sortilin 1 Degradation in Mice

(2015) Jibiao Li et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Sortilin and lipoprotein metabolism

(2014) Alanna Strong et al.   CURRENT OPINION IN LIPIDOLOGY

Targeting sortilin in immune cells reduces proinflammatory cytokines and atherosclerosis

(2014) Martin B. Mortensen et al.   JOURNAL OF CLINICAL INVESTIGATION

Role of anti-inflammatory adipokines in obesity-related diseases

(2014) Koji Ohashi et al.   TRENDS IN ENDOCRINOLOGY AND METABOLISM

Overview of Classification Systems in Peripheral Artery Disease

(2014) Rulon Hardman et al.   SEMINARS IN INTERVENTIONAL RADIOLOGY

Saturated fatty acids activate ERK signaling to downregulate hepatic sortilin 1 in obese and diabetic mice

(2013) Lipeng Bi et al.   JOURNAL OF LIPID RESEARCH

Insulin suppression of apolipoprotein B in McArdle RH7777 cells involves increased sortilin 1 interaction and lysosomal targeting

(2012) Jeffrey M. Chamberlain et al.   BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

Sortilin as a Regulator of Lipoprotein Metabolism

(2012) Alanna Strong et al.   Current Atherosclerosis Reports

The Sorting Receptor Sortilin Exhibits a Dual Function in Exocytic Trafficking of Interferon-γ and Granzyme A in T Cells

(2012) Stefanie Herda et al.   IMMUNITY

Hepatic sortilin regulates both apolipoprotein B secretion and LDL catabolism

(2012) Alanna Strong et al.   JOURNAL OF CLINICAL INVESTIGATION

Large-scale association analysis identifies 13 new susceptibility loci for coronary artery disease

(2011) Heribert Schunkert et al.   NATURE GENETICS

Sort1, Encoded by the Cardiovascular Risk Locus 1p13.3, Is a Regulator of Hepatic Lipoprotein Export

(2010) Mads Kjolby et al.   Cell Metabolism

From noncoding variant to phenotype via SORT1 at the 1p13 cholesterol locus

(2010) Kiran Musunuru et al.   NATURE

Biological, clinical and population relevance of 95 loci for blood lipids

(2010) Tanya M. Teslovich et al.   NATURE

Genetic variation at chromosome 1p13.3 affects sortilin mRNA expression, cellular LDL-uptake and serum LDL levels which translates to the risk of coronary artery disease

(2009) Patrick Linsel-Nitschke et al.   ATHEROSCLEROSIS

Genome-wide association of early-onset myocardial infarction with single nucleotide polymorphisms and copy number variants

(2009) Sekar Kathiresan et al.   NATURE GENETICS

Forty-Three Loci Associated with Plasma Lipoprotein Size, Concentration, and Cholesterol Content in Genome-Wide Analysis

(2009) Daniel I. Chasman et al.   PLoS Genetics

Genome-wide Association Study Identifies Genes for Biomarkers of Cardiovascular Disease: Serum Urate and Dyslipidemia

(2008) Chris Wallace et al.   AMERICAN JOURNAL OF HUMAN GENETICS

Common variants at 30 loci contribute to polygenic dyslipidemia

(2008) Sekar Kathiresan et al.   NATURE GENETICS

Newly identified loci that influence lipid concentrations and risk of coronary artery disease

(2008) Cristen J Willer et al.   NATURE GENETICS

Six new loci associated with blood low-density lipoprotein cholesterol, high-density lipoprotein cholesterol or triglycerides in humans

(2008) Sekar Kathiresan et al.   NATURE GENETICS

Loci influencing lipid levels and coronary heart disease risk in 16 European population cohorts

(2008) Yurii S Aulchenko et al.   NATURE GENETICS